All Pharma News
Humanigen mulls bankruptcy after reverse merger falls through

Humanigen mulls bankruptcy after reverse merger falls through
Nick Paul Taylor FIERCE BIOTECH
25 Jul 2023
Share Share
Humanigen Reports Second Quarter 2022 Financial Results

Humanigen Reports Second Quarter 2022 Financial Results
BUSINESSWIRE
12 Aug 2022
Share Share
Humanigen`s stock sinks as COVID-19 prospect flunks NIH trial

Humanigen`s stock sinks as COVID-19 prospect flunks NIH trial
Nick Paul Taylor FIERCEBIOTECH
14 Jul 2022
Share Share
Humanigen Announces Peer-Reviewed Publication in Thorax in COVID-19 Patients

Humanigen Announces Peer-Reviewed Publication in Thorax in COVID-19 Patients
BUSINESSWIRE
06 Jul 2022
Share Share
NIH/NIAID Locks ACTIV-5/BET-B Database

NIH/NIAID Locks ACTIV-5/BET-B Database
BUSINESSWIRE
30 Jun 2022
Share Share
Humanigen Enters into Agreement with PCI Pharma Services in the UK

Humanigen Enters into Agreement with PCI Pharma Services in the UK
BUSINESSWIRE
16 Jun 2022
Share Share
Humanigen Announces Participation and Presentation at Multiple Conferences

Humanigen Announces Participation and Presentation at Multiple Conferences
BUSINESSWIRE
03 Jun 2022
Share Share
Humanigen Announces Participation and Presentation at H.C. Wainwright Conference

Humanigen Announces Participation and Presentation at H.C. Wainwright Conference
BUSINESSWIRE
24 May 2022
Share Share
Humanigen Reports First Quarter 2022 Financial Results

Humanigen Reports First Quarter 2022 Financial Results
BUSINESSWIRE
05 May 2022
Share Share
Humanigen Announces Peer-Reviewed Publication on Benefits of Lenzilumab

Humanigen Announces Peer-Reviewed Publication on Benefits of Lenzilumab
BUSINESSWIRE
19 Apr 2022
Share Share